May 14, 2014
  • Substitution Treatment Doesn’t Reduce Mortality in Subclinical Hypothyroidism Patients

    A new study adds important data to a longstanding debate: Should subclinical hypothyroidism be treated with levothyroxine? Determining the answer has heightened urgency because the condition is associated with increased risks of hypertension and hypercholesterolemia, which can lead to cardiovascular issues. Find out how researchers determined that thyroid substitution therapy had no effect on overall mortality rates in patients with subclinical hypothyroidism.

  • Initiating Statin Therapy After Prostate Cancer Surgery Reduces Recurrence

    A new retrospective study suggests another important benefit of statins: Reducing the risk of prostate cancer recurrence after radical prostatectomy. How significant was the reduced risk? Here is why the authors recommend that statin therapy be initiated for men undergoing prostate cancer.

  • Intermittent PPI Therapy for Bleeding Ulcers Equal to Bolus-Continuous Infusion Care Plan

    When it comes to bleeding ulcers, a therapy that is both less expensive and more comfortable for patients appears to work just as well as the current standard practice. That’s according to Yale University researchers who found that it might be unnecessary to give patients an initial dose of a proton-pump inhibitor and then administer a maintenance dose through a continuous intravenous line for 72 hours. What did they suggest was a comparable alternative?

  • Prescribers Often Detect Efforts Among Teens to Get ADHD Drugs for Diversion

    Teenagers attempting to get prescriptions for ADHD drugs for diversion to other people or for unapproved uses may not be fooling anyone, but prescribers also aren’t doing much to prevent them from succeeding. That’s according to a new survey presented at the Pediatric Academic Societies meeting in Vancouver. Here are the details.

U.S. Pharmacist Social Connect